As Ketamine becomes more mainstream, and organisations like SIPSA (Society of Interventionist Practitioners South Africa) are forming to potentially guide the use of psychedelic-assisted therapy, one has to realise that we are reaching a new era, where medicines (such as ketamine) that were previously thought to be damaging or innocuous, might in fact have some benefit.1 According to SIPSA’s constitution, one of their aims is:
“To promote the professional and legitimate interests of ketamine and
psychedelic treatments.”2
The growing interest in legal psychedelic treatments can be understood, as few medications offer the immediate relief for suicidal ideation than ketamine can3.
Other psychedelic treatments that are not legal in South Africa may not be on offer at healthcare establishments, but individuals are experimenting with them on their own4 and thus sometimes bringing the psychedelic experience into the therapy space. I have found through consulting the literature5 and my own experience that (without advocating for the use of such substances) creating a safe space where transparency is accessible, insights from psychedelic experiences on psilocybin (“magic mushrooms”) and MDMA can form an important part of the therapeutic process, if the client has chosen to have that experience on their own6.
To find out more, contact Melissa
- https://sipsa.org.za/wp-content/uploads/2024/06/SIPSA-CONSTITUTION-2024.pdf ↩︎
- https://sipsa.org.za/wp-content/uploads/2024/06/SIPSA-CONSTITUTION-2024.pdf ↩︎
- Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj-2021-067194 (Published 02 February 2022) ↩︎ - Pilecki, B., Luoma, J.B., Bathje, G.J. et al. Ethical and legal issues in psychedelic harm reduction and integration therapy. Harm Reduct J 18, 40 (2021). https://doi.org/10.1186/s12954-021-00489-1 ↩︎
- Front. Psychol., 15 March 2021 Sec. Psychopathology Volume 12 – 2021 | https://doi.org/10.3389/fpsyg.2021.645246 ↩︎
- Front. Psychol., 15 March 2021 Sec. Psychopathology Volume 12 – 2021 | https://doi.org/10.3389/fpsyg.2021.645246 ↩︎












